Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 1126 AL 1140

From genes to lifestyle: A multi-dimensional framework for Alzheimer's disease prevention and therapy

Su L, Wang Y.

Ageing Res Rev. 2026 Jan;113:102947. doi: 10.1016/j.arr.2025.102947. Epub 2025 Nov 19.

Therapeutic promise of α-hederin in Alzheimer's disease: Insights into inflammation, oxidative stress, and apoptosis modulation

Chettupalli AK, Gupta N, Bukke SPN, Singh MP, Mandal C.

Biomed Pharmacother. 2025 Dec;193:118803. doi: 10.1016/j.biopha.2025.118803. Epub 2025 Nov 22.

Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer's disease pathogenesis: implications for precision therapeutics

Vaziri Y, Olia JBH, Avci CB, Nourazarian A.

Mol Brain. 2025 Nov 26;18(1):92. doi: 10.1186/s13041-025-01263-1.

Microglia-Mediated Phagocytosis in Alzheimer's Disease: Mechanisms, Heterogeneity, and Therapeutic Insights

Hassan H, Rawlinson C, Lan YL, Jenkins S, Chen R.

Biomolecules. 2025 Nov 20;15(11):1629. doi: 10.3390/biom15111629.

Role of Mitochondrial Calcium Dysregulation in Alzheimer's Disease Pathogenesis

Ebrahimi R, Hatami S, Hashempoor A, Oraee S, Salarvandian S, Faramarzi A, Esmaeilpour K.

Mol Neurobiol. 2025 Nov 29;63(1):214. doi: 10.1007/s12035-025-05465-5.

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer's Disease: Recent Advances and Controversies

Zhang L, Zhang L, Zhao J, Zhang W, Zhang H.

Mol Neurobiol. 2025 Dec 1;63(1):231. doi: 10.1007/s12035-025-05424-0.

[Amyloidogenesis and neurotrophic dysfunction in age-related macular degeneration in correlation with Alzheimer's disease]

Ermilov VV, Nesterova AA.

Arkh Patol. 2025;87(6):61-68. doi: 10.17116/patol20258706161.

White matter hyperintensity regression: Fact or artifact?

Bahrani AA, Nelson PT, Abner EL, Powell DK, Norris CM, Coskun EP, Stowe AM, Goldstein LB, Van Eldik LJ, Gold BT, Wilcock DM, DeCarli CS, Greenberg SM, Jicha GA.

Neurobiol Aging. 2026 Mar;159:33-46. doi: 10.1016/j.neurobiolaging.2025.12.002. Epub 2025 Dec 3.

Toward a Unified Framework in Molecular Neurobiology of Alzheimer's Disease: Revisiting the Pathophysiological Hypotheses

Hein ZM, Karikalan B, Gopalakrishna PK, Dhevi K, Alkatiri A, Hussan F, Mohd Moklas MA, Jagadeesan S, Che Ramli MD, Che Mohd Nassir CMN, Vishnumukkala T.

Mol Neurobiol. 2025 Dec 11;63(1):282. doi: 10.1007/s12035-025-05602-0.

Research Progress of Lipid Metabolism-Mediated Neuroinflammation in Alzheimer's Disease

Shen Y, Wang X, Liu X, Wang G, Hou X, Zhou X.

Cell Mol Neurobiol. 2025 Dec 14;46(1):20. doi: 10.1007/s10571-025-01648-9.

The Blood-Brain Barrier as an Integration Hub in Alzheimer's Disease: How Microbiota Metabolites Modulate Central Signal Processing

Giangiulio O, Maccarone R.

CNS Neurosci Ther. 2025 Dec;31(12):e70703. doi: 10.1002/cns.70703.

From synaptic guardian to neurodegenerative culprit: rewiring the amyloid-β feedback loop in Alzheimer's disease

Herz J.

J Clin Invest. 2025 Dec 15;135(24):e200393. doi: 10.1172/JCI200393. eCollection 2025 Dec 15.

Targeting brain connectivity in Alzheimer's disease with repurposed drugs

Pini L, Imbimbo BP, Griffa A, Allali G, Pomara N.

Ageing Res Rev. 2026 Jan;114:103001. doi: 10.1016/j.arr.2025.103001. Epub 2025 Dec 18.

Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer's Disease

Mishra AK, Jain S.

ACS Chem Neurosci. 2026 Jan 21;17(2):316-334. doi: 10.1021/acschemneuro.5c00750. Epub 2025 Dec 21.

Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer's disease

Soni S, Kaur G.

Cell Calcium. 2026 Jan;133:103107. doi: 10.1016/j.ceca.2025.103107. Epub 2025 Dec 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias